kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer KRAS mutation: from undruggable to
KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Uncovering new therapeutic targets for a common KRAS mutation behind cancer Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



